Eastman Chemical SVP awarded options and RSUs

Caveness Michelle H reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Caveness Michelle H reported acquisition or exercise transactions in this Form 4 filing.

Eastman Chemical Company senior vice president and Chief Manufacturing Officer Michelle H. Caveness reported equity awards granted on February 24, 2026. She received 33,223 employee stock options with one-third becoming exercisable on February 24 of 2027, 2028, and 2029.

She was also granted 4,571 restricted stock units, each representing the right to receive one share of common stock. These RSUs will vest and pay out in unrestricted shares on February 24, 2029, subject to continued employment.

Insider Trade Summary

Grant/Award: 37,794 shares

Grant/Award 2 txns

Insider Caveness Michelle H

Role SVP & Chf. Mfg. Ofc.

Type	Security	Shares	Price	Value
Grant/Award	Employee Stock Option (right to buy)	33,223	$0.00	$0.00
Grant/Award	Restricted Stock Units	4,571	$0.00	$0.00

Holdings After Transaction: Employee Stock Option (right to buy) — 33,223 contracts (Direct); Restricted Stock Units — 4,571 contracts (Direct)

Footnotes (3)

1. F1. One-third of the options become exercisable on February 24, 2027, February 24, 2028, and February 24, 2029, respectively.
2. F2. Each restricted stock unit represents a contingent right to receive one share of issuer common stock.
3. F3. The restricted stock units will vest and payout in unrestricted shares of Company common stock on the third anniversary of the grant date, February 24, 2029, subject to continued employment.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Eastman Chemical (EMN) report for Michelle H. Caveness?

Eastman Chemical reported that SVP and Chief Manufacturing Officer Michelle H. Caveness received equity awards. She was granted 33,223 employee stock options and 4,571 restricted stock units on February 24, 2026, reflecting part of her long-term incentive compensation.

How many stock options were granted to the Eastman Chemical SVP in this Form 4?

Michelle H. Caveness received 33,223 employee stock options. According to the filing, one-third of these options become exercisable on February 24, 2027, another third on February 24, 2028, and the final third on February 24, 2029.

What are the terms of the restricted stock units granted to the Eastman Chemical executive?

The executive received 4,571 restricted stock units, each representing a contingent right to one share of Eastman Chemical common stock. These RSUs will vest and pay out in unrestricted shares on February 24, 2029, provided she remains employed until that date.

When do Michelle H. Caveness’s Eastman Chemical stock options vest?

Her 33,223 stock options vest in three equal installments. One-third becomes exercisable on February 24, 2027, another third on February 24, 2028, and the final third on February 24, 2029, creating a staggered vesting schedule.

When will the Eastman Chemical RSUs granted in this Form 4 pay out?

The 4,571 restricted stock units will vest and pay out on February 24, 2029. At that time, they convert into unrestricted shares of Eastman Chemical common stock, assuming the executive meets the continued employment condition.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/26/2026 - 04:03 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Caveness Michelle H

(Last) (First) (Middle)

200 SOUTH WILCOX DRIVE

(Street)

KINGSPORT TN 37660

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
EASTMAN CHEMICAL CO [ EMN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP & Chf. Mfg. Ofc.

3. Date of Earliest Transaction (Month/Day/Year)
02/24/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	$77.12	02/24/2026		A		33,223		02/24/2027(1)	02/23/2036	Common Stock	33,223	$0	33,223	D
Restricted Stock Units	(2)	02/24/2026		A		4,571		(3)	(3)	Common Stock	4,571	$0	4,571	D

Explanation of Responses:

1. One-third of the options become exercisable on February 24, 2027, February 24, 2028, and February 24, 2029, respectively.

2. Each restricted stock unit represents a contingent right to receive one share of issuer common stock.

3. The restricted stock units will vest and payout in unrestricted shares of Company common stock on the third anniversary of the grant date, February 24, 2029, subject to continued employment.

Remarks:

	/s/ Mark D. Austin, by Power of Attorney for Michelle H. Caveness	02/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.